{"title":"[儿童血管疾病]。","authors":"Marija Jelušić, Marijan Frković","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Primary systemic vasculitides in children are relatively rare diseases. In most cases, they have an unknown\netiology and are defined as the presence of inflammation in the blood vessel wall. Establishing the diagnosis of\nvasculitis is oft en challenging, since the disorder is multisystem in nature with mostly nonspecific symptoms. The last\n10 years have seen significant advances in the field of pediatric vasculitis: the development and validation of classification\ncriteria as well as tools to assess clinical disease activity and disease outcome, the inclusion of pediatric patients in\ninternational multicentre randomized controlled trial designs for therapies of vasculitis, clinical trials for very rare\npediatric vasculitides, and identification of a special group of monogenic vasculitides. In this paper we want to introduce\nreaders to the giant leap in the field of pediatric vasculitis as a result of the hard work of pediatric rheumatologists\nin vasculitis work groups.</p>","PeriodicalId":76426,"journal":{"name":"Reumatizam","volume":"63 Suppl 1 ","pages":"80-5"},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[VASCULITIDES IN CHILDHOOD].\",\"authors\":\"Marija Jelušić, Marijan Frković\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Primary systemic vasculitides in children are relatively rare diseases. In most cases, they have an unknown\\netiology and are defined as the presence of inflammation in the blood vessel wall. Establishing the diagnosis of\\nvasculitis is oft en challenging, since the disorder is multisystem in nature with mostly nonspecific symptoms. The last\\n10 years have seen significant advances in the field of pediatric vasculitis: the development and validation of classification\\ncriteria as well as tools to assess clinical disease activity and disease outcome, the inclusion of pediatric patients in\\ninternational multicentre randomized controlled trial designs for therapies of vasculitis, clinical trials for very rare\\npediatric vasculitides, and identification of a special group of monogenic vasculitides. In this paper we want to introduce\\nreaders to the giant leap in the field of pediatric vasculitis as a result of the hard work of pediatric rheumatologists\\nin vasculitis work groups.</p>\",\"PeriodicalId\":76426,\"journal\":{\"name\":\"Reumatizam\",\"volume\":\"63 Suppl 1 \",\"pages\":\"80-5\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reumatizam\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reumatizam","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Primary systemic vasculitides in children are relatively rare diseases. In most cases, they have an unknown
etiology and are defined as the presence of inflammation in the blood vessel wall. Establishing the diagnosis of
vasculitis is oft en challenging, since the disorder is multisystem in nature with mostly nonspecific symptoms. The last
10 years have seen significant advances in the field of pediatric vasculitis: the development and validation of classification
criteria as well as tools to assess clinical disease activity and disease outcome, the inclusion of pediatric patients in
international multicentre randomized controlled trial designs for therapies of vasculitis, clinical trials for very rare
pediatric vasculitides, and identification of a special group of monogenic vasculitides. In this paper we want to introduce
readers to the giant leap in the field of pediatric vasculitis as a result of the hard work of pediatric rheumatologists
in vasculitis work groups.